Clinical Trials in Houston

Showing 5881-5900 of 17,885 trials

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

NCT04020185

Open-label, dose escalation (Phase I) and dose expansion (Phase IIA) study of patients receiving intra-tumoral IMSA101 alone or in combination with an immune checkpoint inhibitor (ICI) (Phase I and II)

Solid Tumor, Adult

ImmuneSensor Therapeutics Inc.40 participantsStarted Sep 2019

Scottsdale, Arizona, United States • La Jolla, California, United States • Chicago, Illinois, United States +3 more locations

RECRUITINGNA< 1 mile

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

NCT06451133

The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean arterial blood pressure (MAP) goal of 85-90 mmHg, targeting a spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg, or targeting normal hemodynamics, which is a MAP goal of ≥65 mmHg.

Spinal Cord Injuries

The University of Texas Health Science Center, Houston228 participantsStarted Jul 2024

Houston, Texas, United States

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

Find Trials by Condition in Houston

Osia 2 Pediatric Expansion Study

Pegasys® in Patients With Myeloproliferative Diseases

Comprehensive Outcomes for After Cancer Health

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies

CompARing Long terM Outcomes in Chronic Stroke Survivors Across Investigational Assessments Following a Prescribed Upper Extremity Exercise Program

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Pragmatic Trial Examining Oxygenation Prior to Intubation

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

SpineJack System Postmarket Registry

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

A Phase III Trial of e-TNS for the Acute Treatment of Migraine